Prevalence of aphthous stomatitis in patients with inflammatory bowel disease after the treatment with monoclonal antibodies: a systematic review and meta-analysis

BACKGROUND: Currently, the most frequently employed therapies in the treatment of inflammatory bowel diseases (IBD), i.e., Crohn's Disease (CD), Ulcerative Colitis (UC) or unclassified IBD (IBD-U) are monoclonal anti-TNFs and anti-integrin therapies, such as vedolizumab (VDZ). Forty-seven per c...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado-Peralvo, Angel Orión, Montero-Alonso, María, Kewalramani, Naresh, Pérez-Sayáns-García, Mario, Mateos-Moreno, María Victoria, Garcillán-Izquierdo, María Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648636/
https://www.ncbi.nlm.nih.gov/pubmed/36173720
http://dx.doi.org/10.4317/medoral.25528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648636/
https://www.ncbi.nlm.nih.gov/pubmed/36173720
http://dx.doi.org/10.4317/medoral.25528

Ejemplares similares